摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]-2,3-difluoro-5-(hydroxymethyl)phenyl]methylideneamino]acetamide

中文名称
——
中文别名
——
英文名称
N-[[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]-2,3-difluoro-5-(hydroxymethyl)phenyl]methylideneamino]acetamide
英文别名
——
N-[[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]-2,3-difluoro-5-(hydroxymethyl)phenyl]methylideneamino]acetamide化学式
CAS
——
化学式
C16H21F2N3O3
mdl
——
分子量
341.35
InChiKey
XOYCYCRFXWDNAU-AOOOYVTPSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    24
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    74.2
  • 氢给体数:
    2
  • 氢受体数:
    7

文献信息

  • CHEMICAL COMPOUNDS
    申请人:Basarab Gregory Steven
    公开号:US20100261719A1
    公开(公告)日:2010-10-14
    In one aspect, the present invention relates to compounds of Formula (I) and to pharmaceutically acceptable salts thereof, wherein: n is 1 to 4; and R 3 in each occurrence is independently selected from —X—R 5 , —W—R 6 , —C(O)—N(R 3a )—S(O) 2 —R 3b , —C(R 3a )═N—R 3y , C(R 3a )═N—N(R 3a )—C(O)—R 3b , C(R 3a )═N—N(R 3a )—C(O) 2 —R 3b , —C(R 3a )═N—N(R 3y ) 2 , —C(R 3a )═N—N(R 3a )—C(O)—N(R 3y ) 2 , —C(NR 3a ) 2 )═N—R 3y , —C(N(R 3a ) 2 )═N—OR 3y , —C(N(R 3a ) 2 )═N—C(O)—R 3b , —C(N(R 3a ) 2 ═N—S(0) 2 —R 3b , —C(N(R 3a ) 2 )═N—CN, —N═C(R 3y ) 2 , —N(R 3a )—S(O) 2 —N(R 3y ) 2 , —N(R 3a )—N(R 3y 2 , —N(R 3a )—C(O)—N(R 3y ) 2 , —N(R 3a )—C(O)—N(R 3a )—S(O) 2 —R 3b , —N(R 3a )—C(R 3a )═N(R 3y ), —N(R 3a )—C(R 3a )═N—OR 3y , —N(R 3a )—C(R 3a )═N—C(O)—R 3b , —N(R 3a )—C(R 3a )═N—S(O) 2 R— 3b , —N(R 3a )—C(R 3a )═N—CN, —N(R 3a )—C(N(R 3a ) 2 )═N—R 3y , —N(R 3a )—C(N(R 3a ) 2 )═N—OR 3y , —N(R 3a )—C(N(R 3a ) 2 )═N—C(O)—R 3b , —N(R 3a )—C(N(R 3a ) 2 )—N—S(O) 2 —R 3b , —N(R 3a )—C(N(R 3a ) 2 )—N—CN, —O—C(O)—R 3 , and —Si(R 3b ) 3 ; to methods of using them to treat bacterial infections, and to methods for their preparation.
    在一方面,本发明涉及公式(I)的化合物及其药学上可接受的盐,其中:n为1到4;每次R3独立地选择自—X—R5,—W—R6,—C(O)—N(R3a)—S(O)2—R3b,—C(R3a)═N—R3y,C(R3a)═N—N(R3a)—C(O)—R3b,C(R3a)═N—N(R3a)—C(O)2—R3b,—C(R3a)═N—N(R3y)2,—C(R3a)═N—N(R3a)—C(O)—N(R3y)2,—C(NR3a)2)═N—R3y,—C(N(R3a)2)═N—OR3y,—C(N(R3a)2)═N—C(O)—R3b,—C(N(R3a)2═N—S(0)2—R3b,—C(N(R3a)2)═N—CN,—N═C(R3y)2,—N(R3a)—S(O)2—N(R3y)2,—N(R3a)—N(R3y2,—N(R3a)—C(O)—N(R3y)2,—N(R3a)—C(O)—N(R3a)—S(O)2—R3b,—N(R3a)—C(R3a)═N(R3y),—N(R3a)—C(R3a)═N—OR3y,—N(R3a)—C(R3a)═N—C(O)—R3b,—N(R3a)—C(R3a)═N—S(O)2R—3b,—N(R3a)—C(R3a)═N—CN,—N(R3a)—C(N(R3a)2)═N—R3y,—N(R3a)—C(N(R3a)2)═N—OR3y,—N(R3a)—C(N(R3a)2)═N—C(O)—R3b,—N(R3a)—C(N(R3a)2)—N—S(O)2—R3b,—N(R3a)—C(N(R3a)2)—N—CN,—O—C(O)—R3,和—Si(R3b)3;以及使用它们治疗细菌感染的方法和它们的制备方法。
查看更多